1-3 of 3
Angelica Vivero
Close
Sort by
Journal Articles

Perceptions of a Home Blood Transfusion Program Among Patients with Hematologic Malignancies Who Are Newly Diagnosed As Compared to Those with Relapsed/Refractory Disease

Riyana Doshi, Karla Martin Gonzalez, Alavi Hossain, Alexzandra T Gentsch, Angelica Vivero, Lindsay Wilde, Kristin L Rising, Adam F. Binder
Journal: Blood
Blood (2023) 142 (Supplement 1): 2356.
https://doi.org/10.1182/blood-2023-185301
Published: 2023
Journal Articles

NPM-ALK–dependent expression of the transcription factor CCAAT/enhancer binding protein β in ALK-positive anaplastic large cell lymphoma

Leticia Quintanilla-Martinez, Stefania Pittaluga, Cornelius Miething, Margit Klier, Martina Rudelius, Theresa Davies-Hill, Natasa Anastasov, Antonio Martinez, Angelica Vivero, Justus Duyster, Elaine S. Jaffe, Falko Fend, Mark Raffeld
Journal: Blood
Blood (2006) 108 (6): 2029–2036.
https://doi.org/10.1182/blood-2005-10-014258
Published: 2006
Journal Articles

Tissue inhibitor of metalloproteinase 1 (TIMP-1) promotes plasmablastic differentiation of a Burkitt lymphoma cell line: implications in the pathogenesis of plasmacytic/plasmablastic tumors

Liliana Guedez, Antonio Martinez, Shumei Zhao, Angelica Vivero, Stefania Pittaluga, Maryalice Stetler-Stevenson, Mark Raffeld, William G. Stetler-Stevenson
Journal: Blood
Blood (2005) 105 (4): 1660–1668.
https://doi.org/10.1182/blood-2004-04-1385
Published: 2005